Raphael P Luber

6PUBLICATIONS
1CO-AUTHORS
Immunogenetics (incl. genetic immunology)Pacific Peoples psychologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Traditional, complementary and integrative medicine not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 23, 2022
Positioning intestinal ultrasound in a UK tertiary centre: significant estimated clinical role and cost savings.

Raphael P Luber, Bianca Petri, Susanna Meade

|Jan 24, 2022
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort study.

Raphael P Luber, Alexa Duff, Polychronis Pavlidis

|Jul 05, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.

Raphael P Luber, Rhona O'Neill, Sukhpreet Singh

|Sep 04, 2020
Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease.

Raphael P Luber, Luke Dawson, Stephanie Munari

|Jun 20, 2019
Turmeric Induced Liver Injury: A Report of Two Cases.

Raphael P Luber, Clarissa Rentsch, Steve Lontos

Pageof 1

Frequent Collaborators

2 joint publications

Peter M Irving